Award recordCONTRACT

GRIFOLS THERAPEUTICS LLC

PIID VA52815F0014· VHA· 242-NETWORK CONTRACT OFFICE 02· 6505 · DRUGS AND BIOLOGICALS· FY2015· $143,750 net obligations· UEI UFQ3A7GKJ5C7· NC

Description

PROLASTIN FOR THE SYRACUSE VAMC

First action · last action
2014-10-07 · 2015-09-24
Transactions
2
First transaction's obligation
$221,760
Base + all options value (sum of deltas)
$143,750
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P13A0002
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$221,760$0Base award · 2014-10-07 · this action $221,760 · running total $221,760Modification P00001 · 2015-09-24 · this action -$78,010 · running total $143,750
  • Base2014-10-07+$221,760= $221,760
  • Mod P000012015-09-24-$78,010= $143,750
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-10-07+$221,760$221,760PROLASTIN FOR THE SYRACUSE VAMC
Mod P00001· CHANGE ORDER2015-09-24−$78,010$143,750PROLASTIN FOR THE SYRACUSE VAMC

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UFQ3A7GKJ5C7)

AwardOffice · PSC / listingNet obligationsFY
36C26022F0140260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$100,282FY2022
36C26022F0004260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$454,461FY2022
36C26021F0264260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$130,406FY2021
36C26021F0117260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$75,000FY2021
36C26021F0014260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$220,000FY2021
36C26021F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$355,273FY2021

Other recipients under 6505 from 242-NETWORK CONTRACT OFFICE 02 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA52816F0890PFIZER INC242-NETWORK CONTRACT OFFICE 02$10,346FY2016
VA52816F0808BAYER HEALTHCARE PHARMACEUTICALS INC242-NETWORK CONTRACT OFFICE 02$16,180FY2016
VA52816F0388CSL BEHRING L.L.C.242-NETWORK CONTRACT OFFICE 02$1,097FY2016
VA24016E0142MCKESSON CORPORATION242-NETWORK CONTRACT OFFICE 02$5,517,543FY2016
VA52816J0701CEPHEID242-NETWORK CONTRACT OFFICE 02$234,636FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA52815F0014_3600_VA797P13A0002_3600 · retrieved 2026-09-26.